Compounds > carvedilol
Page last updated: 2024-10-24

carvedilol and Angiogenesis, Pathologic

carvedilol has been researched along with Angiogenesis, Pathologic in 1 studies

Research Excerpts

ExcerptRelevanceReference
"BACKGROUND Carvedilol is the first-line drug for the primary prophylaxis of variceal bleeding due to portal hypertension (PHT) in liver cirrhosis."3.88Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats. ( Li, G; Ling, L; Meng, D; Wang, S; Zhang, C, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ling, L1
Li, G1
Meng, D1
Wang, S1
Zhang, C1

Other Studies

1 other study available for carvedilol and Angiogenesis, Pathologic

ArticleYear
Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2018, Nov-18, Volume: 24

    Topics: Angiogenesis Inducing Agents; Animals; Capillaries; Carvedilol; Endothelial Cells; Fibronectins; Hum

2018